• Edit
loading funding rounds…

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues0000000000000000000000000000
% growth(1 %)(5 %)(6 %)6 %4 %3 %-
EBITDA0000000000000000000000000000
% EBITDA margin28 %29 %28 %27 %26 %--
Profit0000000000000000000000000000
% profit margin(24 %)3 %(16 %)(4 %)(10 %)--
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue6 %6 %6 %6 %6 %--

Source: Company filings or news article, Equity research estimates

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo
  • Edit
BiolineRx
exited
Ignyta
ACQUISITION by Roche Dec 2017
Actavis
ACQUISITION by Teva Jul 2015
Cocrystal Discovery
ACQUISITION by Biozone Pharmaceuticals Jan 2014
Cephalon
ACQUISITION by Teva May 2011
Heptares Therapeutics
ACQUISITION by Sosei Group Feb 2015
Auspex Pharmaceuticals
ACQUISITION by Teva Mar 2015
Vaccinex
exited